Evid Invest
Who owns NTLAWhat NTLA owns — n/a

Who owns Intellia Therapeutics, Inc.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of NTLA from SEC Form 13F filings across 312 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 312 institutions disclosed 135.2M shares of Intellia Therapeutics, Inc. worth $1.63B — about 96.5% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.

312

13F holders

$1.63B

value, 2026 filers

96.5%

of shares outstanding (135.2M sh)

35

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of NTLA's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1BlackRock, Inc.16.0M$193.4M0.0%11.4%+4.1%
2ARK Investment Management LLC15.9M$192.1M1.1%11.4%-5.6%
3STATE STREET CORP7.8M$94.2M0.0%5.6%-15.4%
4VANGUARD PORTFOLIO MANAGEMENT LLC7.4M$89.1M0.0%5.3%+0.8%
5D. E. Shaw & Co., Inc.6.1M$73.1M0.0%4.3%-5.9%
6VANGUARD CAPITAL MANAGEMENT LLC6.0M$72.9M0.0%4.3%+0.2%
7TWO SIGMA INVESTMENTS, LP4.7M$56.8M0.0%3.4%-10.0%
8FMR LLC4.7M$56.6M0.0%3.3%-1.7%
9REGENERON PHARMACEUTICALS, INC.3.7M$44.7M24.9%2.6%0.0%
10Amova Asset Management Americas, Inc.3.6M$43.5M0.5%2.6%+24.6%
11Sumitomo Mitsui Trust Group, Inc.3.6M$43.5M0.0%2.6%+24.4%
12GEODE CAPITAL MANAGEMENT, LLC3.5M$42.1M0.0%2.5%-4.0%
13DIMENSIONAL FUND ADVISORS LP2.6M$31.4M0.0%1.9%-0.1%
14Contrarius Group Holdings Ltd2.4M$29.3M1.4%1.7%+24.4%
15ARMISTICE CAPITAL, LLC2.4M$28.5M0.3%1.7%+57.6%
16GOLDMAN SACHS GROUP INC2.2M$26.1M0.0%1.5%-4.3%
17VOLORIDGE INVESTMENT MANAGEMENT, LLC2.1M$25.3M0.1%1.5%+1.7%
18MORGAN STANLEY2.1M$24.9M0.0%1.5%+19.1%
19HRT FINANCIAL LP1.8M$22.3M0.0%1.3%+48.6%
20JUPITER ASSET MANAGEMENT LTD1.6M$19.8M0.1%1.2%-11.3%
21FEDERATED HERMES, INC.1.6M$19.0M0.0%1.1%+117.1%
22Connor, Clark & Lunn Investment Management Ltd.1.4M$16.7M0.0%1%+54.1%
23CHARLES SCHWAB INVESTMENT MANAGEMENT INC1.3M$15.7M0.0%0.9%+7.7%
24NORTHERN TRUST CORP1.3M$15.3M0.0%0.9%0.0%
25UBS Group AG1.2M$15.0M0.0%0.9%-42.1%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.